President
PTI - Pharmaceutical Technologies International
Albuquerque, New Mexico
Dr. Metin Çelik is the founder and president of Pharmaceutical Technologies International, Inc. (PTI Inc.), with over three decades of global experience in pharmaceutical formulation, compaction science, and regulatory compliance. He has served as a consultant to more than 50 companies and as an expert witness in over 35 pharmaceutical patent litigations in the U.S. and Canada, providing technical insight on formulation, process, and regulatory matters.
Before founding PTI in 1997, he worked with Novartis in Switzerland and Turkey, and later with Smith Kline & French Laboratories (now GSK), where he establsihed the first two compaction simulator systems in both industry and academia in the Western Hemisphere.
He has held academic appointments at Rutgers University, NEU and EMU and currently serves as Adjunct Professor at the UNM..
At PTI, Dr. Çelik leads the integration of AI, QbD, PAT into advanced pharmaceutical development. His current initiative is the use of AI/ML in formulation and process development and PAI Expert Systems.\
An internationally recognized speaker, Dr. Çelik has delivered more than 300 invited presentations worldwide and has authored numerous publications. He is a founding and past chair of several AAPS Focus Groups, including Expert Systems and Excipients.
Disclosure information not submitted.
Machine Learning-Driven Formulation and Process Design for Solid Dosage Forms
Wednesday, November 12, 2025
3:45 PM - 4:00 PM CT